{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T17:48:21Z","timestamp":1789321701677,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Seqirus Pty Ltd"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.07.036","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T11:09:03Z","timestamp":1532603343000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6\u201359\u202fmonths of age: A phase 3, randomized, noninferiority study"],"prefix":"10.1016","volume":"37","author":[{"given":"Victoria A.","family":"Statler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank R.","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Airey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne C.","family":"Sawlwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Graves Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Matassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.036_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2013 United States, 2017\u201318 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2018.07.036_b0010","unstructured":"Centers for Disease Control and Prevention. Estimated influenza illnesses and hospitalizations averted by vaccination \u2014 United States, 2014\u201315 influenza season; 2015 <https:\/\/www.cdc.gov\/flu\/about\/disease\/2014-15.htm> [accessed 30 January 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0015","unstructured":"Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Status Report as at 2 July 2010. Updated 24 September 2010 <https:\/\/www.tga.gov.au\/sites\/default\/files\/alerts-medicine-seasonal-flu-100702.pdf> [accessed 24 February 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0020","unstructured":"Therapeutic Goods Administration. Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children. 8 October 2010 <https:\/\/www.tga.gov.au\/sites\/default\/files\/alerts-medicine-seasonal-flu-101008.pdf> [accessed 24 February 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0025","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.vaccine.2014.03.035","article-title":"Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine","volume":"32","author":"Rockman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.036_b0030","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2017.02.066","article-title":"Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: a phase 3, randomized noninferiority study","volume":"35","author":"Treanor","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.036_b0035","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.vaccine.2017.03.028","article-title":"Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: a phase 3, randomized noninferiority study","volume":"35","author":"Airey","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.036_b0040","unstructured":"World Medical Association Declaration of Helsinki \u2013 Ethical principles for medical research involving human subjects; 2013 <https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/> [accessed 30 January 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0045","unstructured":"U.S. Food and Drug Administration. Guidance for industry. E6 good clinical practice: consolidated guidance; 1996 <https:\/\/clinicalcenter.nih.gov\/ccc\/clinicalresearch\/guidance.pdf> [accessed 30 January 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2018.07.036_b0055","unstructured":"U.S. Food and Drug Administration. Guidance for industry. Clinical data needed to support the licensure of pandemic influenza vaccines; 2007 <https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm091985.pdf> [accessed 30 January 2018]."},{"key":"10.1016\/j.vaccine.2018.07.036_b0065","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jit091","article-title":"A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3\u201317 years","volume":"207","author":"Domachowske","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.036_b0070","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2014.10.024","article-title":"Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children","volume":"32","author":"Brady","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.036_b0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/INF.0000000000000254","article-title":"Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T17:34:43Z","timestamp":1545240883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18310053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18310053"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6\u201359\u202fmonths of age: A phase 3, randomized, noninferiority study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}